Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel and Gemcitabine Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
NCT04077983Phase 2Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel in intrahepatic cholangiocarcinoma (ICC), sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT04077983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04077983.